Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Women's perspective of botulinum toxin treatment for overactive bladder symptoms.

Digesu GA, Panayi D, Hendricken C, Camarata M, Fernando R, Khullar V.

Int Urogynecol J. 2011 Apr;22(4):425-31. doi: 10.1007/s00192-010-1315-x. Epub 2010 Nov 24.

PMID:
21104404
2.

Validity of the Rome III Criteria in assessing constipation in women.

Digesu GA, Panayi D, Kundi N, Tekkis P, Fernando R, Khullar V.

Int Urogynecol J. 2010 Oct;21(10):1185-93. doi: 10.1007/s00192-010-1179-0. Epub 2010 May 21.

PMID:
20495784
3.

A persistent bladder erosion with ureteric involvement following mesh augmented repair of cystocele.

Derpapas A, Digesu GA, Panayi D, Vale J, Khullar V.

Am J Obstet Gynecol. 2010 Jun;202(6):e5-7. doi: 10.1016/j.ajog.2010.03.005. Epub 2010 Apr 28.

PMID:
20430352
4.

Reliability and normal ranges for the Patient's Perception of Intensity of Urgency Scale in asymptomatic women.

Cartwright R, Panayi D, Cardozo L, Khullar V.

BJU Int. 2010 Mar;105(6):832-6. doi: 10.1111/j.1464-410X.2009.08846.x. Epub 2009 Oct 10.

5.

Should we explain lower urinary tract symptoms to patients?

Digesu GA, Khullar V, Panayi D, Calandrini M, Gannon M, Nicolini U.

Neurourol Urodyn. 2008;27(5):368-71.

PMID:
17943984
6.

Supplemental Content

Loading ...
Support Center